MEDTEQ+ and OBIO® Join Forces to Accelerate the Development of AgeTech Innovations Across Canada

Montreal, May 6, 2025 – MEDTEQ+ and OBIO^®, two not-for-profit organizations offering programs to support companies in the health technology development sector in Canada, are pleased to join forces to accelerate Canadian entrepreneurs’ innovations and increase collaboration in developing these innovations to deploy across Canada, especially in AgeTech.

Increased Collaboration Between Provinces

Building on a long-standing relationship, the partnership between MEDTEQ+ and OBIO^® will further advance the AgeTech sector through the envisAGE initiative and continue to strengthen the positioning of Canadian companies in the health technology sector. By leveraging their programs, networks and expertise, MEDTEQ+ and OBIO^® plan to offer better support to innovative Canadian companies, from ideation to commercialization, and to maximize financing and funding opportunities for collaborative projects in the Canadian healthcare sector.

“This partnership is in line with MEDTEQ+’s desire to pursue its pan-Canadian collaborations aimed at optimizing the success potential of our companies and propelling their access to other markets, generating both economic spin-offs for our sector and tangible, validated solutions for Canadians,” says Annie-Kim Gilbert, President and CEO of MEDTEQ+.

“By joining forces and leveraging our extensive pan-Canadian networks, OBIO^® and MEDTEQ+, through the envisAGE initiative, are creating a powerful support system for companies in the AgeTech space. This new collaboration builds on existing successful partnerships with MEDTEQ+ and AGE-WELL, further amplifying our combined efforts in supporting entrepreneurs and driving innovation in the sector.” adds Dr. Maura Campbell, President and CEO of OBIO^®.

MEDTEQ+ and OBIO^® have a long history of supporting Canadian innovators to bring their innovations to market and accelerate their path to commercialization. Since 2012, MEDTEQ+ has coordinated over 40 calls for projects and supported more than 200 innovative projects thanks to the support of the provincial and federal governments, enabling the implementation of over 450 health innovations in various health and service establishments. Over the past few years, MEDTEQ+ has also spearheaded a number of digital health initiatives, ranging from pandemic response, AgeTech, space medicine, autonomous healthcare and FemTech technologies for women’s health. MEDTEQ+ is the initiator of the Beachhead networks, comprised of 14 centres of excellence, including nine specialized centres in aging, whose mandate is to validate and evaluate the innovations of Canadian small & medium enterprises (SMEs) in real-world conditions.

OBIO^® is an integral part of the life sciences and health tech ecosystem, supporting companies to bring their products to market. Since 2018, through commercialization and technology adoption programming, OBIO^®, has successfully completed 125+ adoption projects, and supported SMEs in raising $1.6 billion in dilutive funding along with $30 million in sales. OBIO’s Early Adopter Health Network (EAHN™) matches Canadian commercial-ready health technology SMEs with a national network of 80+ healthcare organizations to evaluate technologies in a real-world setting and to facilitate their broad adoption into the healthcare system. Through its Life Sciences Critical Technologies & Commercialization (LSCTC) Centre of Excellence, supported by the Government of Ontario, OBIO^® is prioritizing the evaluation and implementation of new solutions using critical technologies: 5G and advanced networks, ethical artificial intelligence, blockchain, cybersecurity, quantum and robotics.

Technology adoption through OBIO’s EAHN™ program and the LSCTC Centre of Excellence, in partnership with envisAGE, will provide simultaneous support in the fastest, most seamless way possible to Ontario’s AgeTech companies. The purpose of this collaboration is to facilitate the adoption of innovative solutions that can improve the quality of life of our aging population.

– 30 –

About OBIO^®

Founded in 2009, OBIO^® is a not-for-profit, membership-based organization engaged in strategy, programming, policy development and advocacy to address the needs of the next generation of companies developing innovative human health products. OBIO^® supports early-stage and venture-backed life sciences and health tech companies enabling them to raise capital, hire and train industry-ready talent, facilitate the commercialization and market adoption of their technologies in health systems, and access infrastructure. OBIO^® advances this goal through collaborative partnerships with industry, the investment community, academia, the healthcare system and government. For more information, please visit obio.ca and follow OBIO^® on LinkedIn and X.

About MEDTEQ+

MEDTEQ+, a pan-Canadian industrial research and innovation consortium, is dedicated to helping healthcare technology companies bring their innovations to market, accelerate economic growth and contribute to improving the health of the population. Through its unique expertise and collaborative approach, MEDTEQ+ offers support services across the innovation continuum, validation and integration of technological solutions in real-life environments, financing and networking with key ecosystem partners to accelerate the commercialization of innovative healthcare technologies. MEDTEQ+ also supports the envisAGE initiative, which aims to catalyze the AgeTech ecosystem and stimulate technological development in supporting aging. MEDTEQ+ relies, among others, on financial support from the Government of Quebec, the Government of Canada, the private sector and complementary partners to foster research and industry relations.

For more information, visit www.medteq.ca or join our communities on LinkedIn or Bluesky.

Media Contacts:

MEDTEQ+
Josée Laflamme
Communication Director, MEDTEQ+
josee.laflamme@medteq.ca

OBIO^®
Doriane Rey
Senior Manager, Marketing & Communications
dorianerey@obio.ca